Amer, Hana https://orcid.org/0000-0002-0248-7241
Marotti, Sally https://orcid.org/0000-0003-3098-6096
Inglis, Joshua M. https://orcid.org/0000-0003-0486-9013
Widagdo, Imaina https://orcid.org/0000-0002-0669-0183
Goldsworthy, Sharon
Johnson, Jacinta https://orcid.org/0000-0003-4786-022X
Kalisch Ellett, Lisa https://orcid.org/0000-0001-5063-6128
Funding for this research was provided by:
Australian Government Research Training Program Scholarship
Medical Research Future Fund - Clinician Researchers Initiative - 2023 Clinician Researchers: Applied Research in Health Grant Opportunity (Stream 2: MRF2031745)
University of South Australia
Article History
Received: 26 June 2025
Accepted: 1 August 2025
First Online: 28 August 2025
Change Date: 5 October 2025
Change Type: Update
Change Details: The third author's name has been corrected to “Joshua M. Inglis”
Ethics approval
: Approval to conduct the study was obtained from the Central Adelaide Local Health Network Human Research Ethics Committee (approval number: 16945, approved 08/11/202) and the University of South Australia Human Research Ethics Committee (approval number: 205819, approved 07/09/2023).
: A waiver of consent was obtained from the Central Adelaide Local Health Network Human Research Ethics Committee (approval number: 16945, approved 08/11/2022) and the University of South Australia Human Research Ethics Committee (Approval Number: 205819, approved 07/09/2023). All patient data presented in this report have been de-identified and grouped. No individual patient data or results have been presented.
: Financial interests: This study did not receive any external funding and was conducted with in-kind support from SA Pharmacy. The authors have no relevant financial interests to disclose. Non-financial interests: Three of the authors (HA, SG, LKE) were on the statewide multi-disciplinary steering committee for the collaborative pharmacist prescribing model included in this study. One of the authors (SM) was on the statewide credentialing committee for the collaborative pharmacist prescribing model included in this study.